Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: Regulation by steroid treatment

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 9, 2006, Pages 1412-1418

  Schäffler, Andreas ^a   Fürst, Alois ^a   Büchler, Christa ^a   Paul, Gisela ^a   Rogler, Gerhard ^a   Schölmerich, Jürgen ^a   Herfarth, Hans ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adipose tissue; CCL5; Creeping fat; Crohn's disease; IL 10; Inflammatory bowel disease; RANTES

Indexed keywords

INTERLEUKIN 10; RANTES; STEROID;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DIVERTICULITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENTERY; PATHOGENESIS; PRIORITY JOURNAL; STEROID THERAPY; SUPERNATANT;

EID: 33746597777     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04300.x     Document Type: Article

References (28)

1. Schall TJ, Jongstra J, Dyer BJ et al. A human T-cell-specific molecule is a member of a new gene family. J. Immunol. 1988; 141: 1018-25.
2. McCormack G, Moriarty D, O'Donoghue DP, McCormick PA, Sheahan K, Baird AW. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm. Res. 2001; 50: 491-5.
3. Mazzucchelli L, Hauser C, Zgraggen K et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J. Pathol. 1996; 178: 201-6.
4. Kudo T, Nagata S, Aoyagi Y et al. Polarized production of T-helper cell type 1 cells in Peyer's patches in Crohn's disease. Digestion 2004; 70: 214-25.
5. Jeziorska M, Haboubi N, Schofield P, Woolley DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J. Pathol. 2001; 194: 484-92.
6. Kmiec Z. Cytokines in inflammatory bowel disease. Arch. Immunol. Ther. Exp. 1998; 46: 143-5546.
7. Berrebi D, Banerjee A, Paris R et al. In situ RANTES and interferon-gamma gene expression in pediatric small bowel Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 1997; 25: 371-6.
8. Oki M, Ohtani H, Kinouchi Y et al. Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response? Lab. Invest. 2005; 85: 137-15.
9. Scheerens H, Hessel E, de Waal-Malefyt R, Leach MW, Rennick D. Characterization of chemokines and chemokine receptors in two murine models of inflammator bowel disease. IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+Cd45Rbhigh T cells. Eur. J. Immunol. 2001; 31: 1465-74.
10. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000; 11: 327-32.
11. Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 1996; 2: 800-3.
12. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003; 112: 1821-30.
13. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003; 112: 1796-808.
14. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 2000; 16: 145-71.
15. Pritts EA, Zhao D, Ricke E, Waite L, Taylor RN. PPAR-gamma decreases endometrial stromal cell transcription and translation of RANTES in vitro. J. Clin. Endocr. Metab. 2002; 87: 1841-1.
16. Pritts EA, Zhao D, Sohn SH, Chao VA, Waite LL, Taylor RN. Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element. Fertil. Steril. 2003; 80: 415-20.
17. Wada K, Nakajima A, Blumberg RS. PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease. Trends Mol. Med. 2001; 7: 329-31.
18. Desreumaux P, Ernst O, Geboes K et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterolgoy 1999; 117: 73-81.
19. Barbier M, Vidal H, Desreumaux P et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseaseas. Gastroenterol. Clin. Biol. 2003; 27: 987-91.
20. Rogler G, Gelbmann CM, Vogl D et al. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand. J. Gastroenterol. 2001; 36: 389-98.
21. Lewis JD, Lichtenstein GR, Stein RB et al. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am. J. Gastroenterol. 2001; 96: 3323-8.
22. Desreumaux P, Dubuquoy L, Nutten S et al. Attenuation of colon inflammation through activators of retinoid X receptor (RXR) / peroxisome proliferator-activated receptor γ (PPARγ) heterodimer: a basis for new therapeutic strategies. J. Exp. Med. 2001; 193: 827-38.
23. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2001; 145: 2273-82.
24. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect 'Cushings disease of the omentum'? Lancet 1997; 349: 1210-13.
25. Leal-Cerro A, Soto A, Martinez MA et al. Influence of cortisol status on leptin secretion. Pituitary 2001; 4: 111-16.
26. Askari H, Liu J, Dagogo-Jack S. Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin. Int. J. Obes. Relat. Metab. Disord. 2000; 24: 1254-9.
27. Fried M. Corticosteroid effects on cytokines and chemokines. Allergy Asthma Proc. 1999; 20: 147-59.
28. Di Gioacchino M, Verna N, Cavallucci E et al. Steroid and antihistamines modulate RANTES release in cultured peripheral blood mononuclear cells of atopic patients. Int. J. Immunopathol. Pharmacol. 2002; 15: 27-34.